TREATMENT OF EXPERIMENTAL VISCERAL LEISHMANIASIS IN A T-CELL-DEFICIENT HOST - RESPONSE TO AMPHOTERICIN-B AND PENTAMIDINE

被引:42
作者
MURRAY, HW [1 ]
HARIPRASHAD, J [1 ]
FICHTL, RE [1 ]
机构
[1] NEW YORK HOSP,DEPT PHARM,NEW YORK,NY 10021
关键词
D O I
10.1128/AAC.37.7.1504
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In experimental visceral leishmaniasis, euthymic but not athymic (nude) BALB/c mice respond to conventional treatment with pentavalent antimony, indicating that the in vivo efficacy of antimony is T cell dependent. This finding correlates with frequent antimony treatment failures for T-cell-deficient patients with visceral leishmaniasis. To determine whether the in vivo efficacies of alternative antileishmanial agents also require T cells, Leishmania donovani-infected euthymic and nude BALB/c mice were treated with pentamidine or amphotericin B. Pentamidine induced leishmanistatic activity in euthymic mice but had little effect in nude mice. In contrast, amphotericin B exerted potent leishmanicidal activities in both euthymic and nude animals. These results suggest that amphotericin B may be of particular use for T-cell-deficient patients with visceral leishmaniasis.
引用
收藏
页码:1504 / 1505
页数:2
相关论文
共 13 条
[1]   VISCERAL LEISHMANIASIS - ANOTHER HIV-ASSOCIATED OPPORTUNISTIC INFECTION - REPORT OF 8 CASES AND REVIEW OF THE LITERATURE [J].
ALTES, J ;
SALAS, A ;
RIERA, M ;
UDINA, M ;
GALMES, A ;
BALANZAT, J ;
BALLESTEROS, A ;
BUADES, J ;
SALVA, F ;
VILLALONGA, C .
AIDS, 1991, 5 (02) :201-207
[2]  
BERMAN JD, 1988, REV INFECT DIS, V10, P560
[3]   ACTIVITY OF AMPHOTERICIN-B CHOLESTEROL DISPERSION (AMPHOCIL) IN EXPERIMENTAL VISCERAL LEISHMANIASIS [J].
BERMAN, JD ;
KSIONSKI, G ;
CHAPMAN, WL ;
WAITS, VB ;
HANSON, WL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :1978-1980
[4]   AN INVITRO MODEL FOR INVESTIGATION OF CHEMOTHERAPEUTIC-AGENTS IN LEISHMANIASIS [J].
BERMAN, JD ;
WYLER, DJ .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (01) :83-86
[5]   LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF VISCERAL LEISHMANIASIS [J].
CROFT, SL ;
DAVIDSON, RN ;
THORNTON, EA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :111-118
[6]   LIPOSOMAL AMPHOTERICIN-B IN DRUG-RESISTANT VISCERAL LEISHMANIASIS [J].
DAVIDSON, RN ;
CROFT, SL ;
SCOTT, A ;
MAINI, M ;
MOODY, AH ;
BRYCESON, ADM .
LANCET, 1991, 337 (8749) :1061-1062
[7]   VISCERAL LEISHMANIASIS IN IMMUNOCOMPROMISED HOSTS [J].
FERNANDEZGUERRERO, ML ;
AGUADO, JM ;
BUZON, L ;
BARROS, C ;
MONTALBAN, C ;
MARTIN, T ;
BOUZA, E .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (06) :1098-1102
[8]   AMPHOTERICIN VERSUS PENTAMIDINE IN ANTIMONY-UNRESPONSIVE KALA-AZAR [J].
MISHRA, M ;
BISWAS, UK ;
JHA, DN ;
KHAN, AB .
LANCET, 1992, 340 (8830) :1256-1257
[9]   REQUIREMENT FOR T-CELLS AND EFFECT OF LYMPHOKINES IN SUCCESSFUL CHEMOTHERAPY FOR AN INTRACELLULAR INFECTION - EXPERIMENTAL VISCERAL LEISHMANIASIS [J].
MURRAY, HW ;
OCA, MJ ;
GRANGER, AM ;
SCHREIBER, RD .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1253-1257
[10]   IMMUNOCHEMOTHERAPY FOR INTRACELLULAR LEISHMANIA-DONOVANI INFECTION - GAMMA-INTERFERON PLUS PENTAVALENT ANTIMONY [J].
MURRAY, HW ;
BERMAN, JD ;
WRIGHT, SD .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :973-978